1 / 4

Radiodermatitis Market

Radiodermatitis is a skin condition which involves skin becomes dry, itchy, and inflamed, which leads to redness, swelling, scaling, and crusting. Radiodermatitis is a bodyu2019s response to ionizing radiation, which is delivered in cancer patients and in imaging techniques. It is also known as x-ray dermatitis, radiation dermatitis, radiation-induced skin reactions, or radiation injury. The condition can also be a result of nuclear attacks and disasters.

Aarav658
Download Presentation

Radiodermatitis Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Radiodermatitis Market: Increased Healthcare Expenditure Set to Motivate Growth Radiodermatitis, also known as x-ray dermatitis, radiation dermatitis, radiation-induced skin reactions, or radiation injury, is a side effect of external beam ionizing radiation. Radiotherapy, used in the treatment of cancer or other diseases, is a major cause of radiodermatitis. The condition can also be a result of nuclear attacks and disasters. The global radiodermatitis market is estimated to account for US$ 360.5 Mn in terms of value and is expected to reach US$ 472.8 Mn by the end of 2028. Restraints of the Global Radiodermatitis Market Major factors hampering the growth of the radiodermatitis market during the forecast period constitutes of introduction of technologically advanced radiation therapy techniques and instruments which reduce the risk of Radiodermatitis. Key features of the study:  This report provides in-depth analysis of the global radiodermatitis market and provides market size (US$ Mil- lion) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2018, as the base year  It elucidates potential revenue opportunity across different segments and explains attractive investment propo- sition matrix for this market  This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players  It profiles leading players in the global radiodermatitis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key develop- ments, strategies, and future plans Get more information on this report: Request Sample Pages Global Radiodermatitis Market: Drivers Increasing prevalence of cancer is expected to propel growth of the global radiodermatitis market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

  2. Moreover, R&D of new therapies for the treatment of radiodermatitis is also expected to aid in growth of the market. For instance, in December 2019, Kannalife, Inc. filed a new U.S. Patent for its proprietary and novel CBD-like molecules for the treatment of radiodermatitis and other skin disorders. Detailed Segmentation  Global Radiodermatitis Market, By Product Type: oTopical Agents  Corticosteroids  Hydrophilic Creams  Others oOral Medication  Corticosteroids  Other (Analgesic & Anti-Inflammatory) oDressings  Hydrogel  Hydrocolloid  No Sting Barrier Film  Honey Impregnated Dressing  Silicone coated Dressing  Others  Global Radiodermatitis Market, By Distribution Channel: oHospital Pharmacies oRetail Pharmacies oOnline Pharmacies  Global Radiodermatitis Market, By Geography: oNorth America  By Product Type  Topical Agents  Corticosteroids

  3. Hydrophilic Creams  Others  Oral Medication  Corticosteroids  Other (Analgesic & Anti-Inflammatory)  Dressings  Hydrogel  Hydrocolloid  No Sting Barrier Film  Honey Impregnated Dressing  Silicone coated Dressing  Others Table of Contents Research Objective and Assumption Research Objectives Assumptions Abbreviations Market Preview Report Description Market Definition and Scope Executive Summary Market Snippet, By Product Type Market Snippet, By Distribution Channel Coherent Opportunity Map (COM) Market Dynamics, Regulations, and Trends Analysis Market Dynamics Drivers Restraints Market Opportunities Impact Analysis Key Developments Technological Advancement Regulatory Scenario Purchase This Premium Report With Flat USD 2000 OFF

  4. About US: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defence, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post- COVID-19 and continue to deliver measurable, sustainable results for our clients. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: sales@coherentmarketinsights.com

More Related